Latest Articles

Publication Date
A novel senotherapeutic strategy with azithromycin for preventing endometriosis progression.

Endometriosis is an estrogen-dependent chronic inflammatory disease, however the mechanisms underlying inflammation remain unclear. Non-hormonal drugs that can prevent endometriosis progression and resolve endometriotic infertility are urgently required. We thus …

Published: March 26, 2025, midnight
New research paves the way for non-hormonal endometriosis treatments - News-Medical.Net

New research paves the way for non-hormonal endometriosis treatments News-Medical.Net

Published: March 23, 2025, 3:51 a.m.
Researchers make progress toward non-hormonal treatment for endometriosis - Medical Xpress

Researchers make progress toward non-hormonal treatment for endometriosis Medical Xpress

Published: March 22, 2025, 10:05 a.m.
MSU researchers make progress toward non-hormonal treatment for endometriosis - EurekAlert

MSU researchers make progress toward non-hormonal treatment for endometriosis EurekAlert

Published: March 21, 2025, 11:38 p.m.
MSU Researchers Make Progress Toward Non-Hormonal Treatment for Endometriosis | Newswise - Newswise

MSU Researchers Make Progress Toward Non-Hormonal Treatment for Endometriosis | Newswise Newswise

Published: March 21, 2025, 10:15 p.m.
MSU Advances Non-Hormonal Endometriosis Treatment - Mirage News

MSU Advances Non-Hormonal Endometriosis Treatment Mirage News

Published: March 21, 2025, 8:56 p.m.
MSU researchers make progress toward non-hormonal treatment for endometriosis - MSUToday

MSU researchers make progress toward non-hormonal treatment for endometriosis MSUToday

Published: March 21, 2025, 2 p.m.
A Fibronectin (FN)-Silk 3D Cell Culture Model as a Screening Tool for Repurposed Antifibrotic Drug Candidates for Endometriosis.

This study advances sustainable pharmaceutical research for endometriosis by developing in vitro 3D cell culture models of endometriotic pathophysiology that allow antifibrotic drug candidates to be tested. Fibrosis is a …

Published: Feb. 19, 2025, midnight
Reprogramming peritoneal macrophages with outer membrane vesicle-coated PLGA nanoparticles for endometriosis prevention.

Endometriosis is a chronic inflammatory disease that primarily affects women of reproductive age. The current hormonal treatments are unsuitable for women who wish to conceive, highlighting the need for non-hormonal …

Published: Feb. 17, 2025, midnight
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Jan. 20, 2025, 10:56 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!